KI-Beratung Beta

Produktbild: Nanocarriers for Targeted Therapy and Management of Ovarian Cancer
Vorbesteller Neu

Nanocarriers for Targeted Therapy and Management of Ovarian Cancer

Fr. 195.00

inkl. gesetzl. MwSt., Versandkostenfrei


Portrait

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made...

Portrait

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs.

Dr. Swapnil Sharma is a Professor in the Department of Pharmacy at Banasthali Vidyapith, Banasthali, Rajasthan, India. With over 19 years of academic and professional experience, he specializes in fundamental preclinical pharmacology. He has published over 250 research papers, contributed 10+ book chapters, and holds five granted patents, including 1 US and 1 European Patent. He has guided dozens of Ph.D. and several PG scholars. Also, he is a regular reviewer of various peer review journals belonging to various renowned publishing houses .

Dr. Dinky Gajiwala is a consultant medical oncologist at Nirali Cancer Hospital, Navsari, with comprehensive clinical expertise in the management of adult solid tumors and hematological malignancies, including breast, gynecological, gastrointestinal, thoracic, urological, head-and-neck cancers, sarcomas, lymphoma, myeloma, and leukemia. She completed her MBBS from Veer Narmad South Gujarat University, followed by DNB Internal Medicine training at Holy Family Hospital and DNB Medical Oncology at Prince Aly Khan Hospital. Her clinical practice includes administration of chemotherapy, targeted therapy, immunotherapy, and palliative oncology care, along with procedures such as intrathecal chemotherapy and peripherally inserted central catheter placement. She is also experienced in both autologous and allogeneic bone marrow transplantation. Dr. Gajiwala actively participates in international oncology communities and is a member of European Society for Medical Oncology, American Society of Clinical Oncology, and Indian Society of Medical and Pediatric Oncology.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.03.2027

Herausgeber Devesh U. Kapoor + weitere
Verlag Elsevier

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.03.2027

Herausgeber
Verlag Elsevier
Seitenzahl

270

Maße (L/B)

23.5/19.1 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-49446-8

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Nanocarriers for Targeted Therapy and Management of Ovarian Cancer
  • 1. Clinical Landscape of Ovarian Cancer and Opportunities for Nanomedicine
    2. Ovarian Cancer Biology and Molecular Targets for Nanocarrier Delivery
    3. Liposomes as Nanocarriers for Ovarian Cancer Therapy
    4. Solid Lipid Nanoparticles for Controlled Delivery in Ovarian Cancer
    5. Polymeric Nanoparticles for Ovarian Cancer Management
    6. Polymeric Micelles for Targeted Delivery
    7. Dendrimers as Nanoscale Delivery Systems
    8. Mesoporous Silica Nanoparticles in Ovarian Cancer Therapy
    9. Niosomes and Ethosomes in Ovarian Cancer Management
    10. Nanogel Based Delivery Systems
    11. Hydrogel Based Nanocarriers for Localized Therapy
    12. Exosome and Extracellular Vesicle Based Nanocarriers
    13. Artificial Intelligence in Nanocarrier Design and Ovarian Cancer Management
    14. Regulatory Science and Translational Bottlenecks
    15. Clinical Trial Landscape of Nanomedicine in Ovarian Cancer
    16. Pharmacokinetics, Biodistribution, and Safety Profiling
    17. Clinical Integration of Nanomedicine in Ovarian Cancer Care